Fully continuous biosimilar manufacturing framework: A case study

14th June 2018 | 9:30AM GMT, 2PM IST | Samir Varma, Head of Manufacturing, Enzene Biosciences |ATTEND FREE WEBINAR


  • Strategies in establishing a fully continuous biosimilar framework
  • Overcoming challenges connecting upstream and downstream sections in building continuous processing system


Presented by Samir Varma, Head of Manufacturing, Enzene Biosciences

Samir has more than 16 years of experience in the Biotech Industry. Having worked at various mid-size biotech and large pharma such as Medarex, Bristol Myers Squibb, Celgene in NJ, USA and Lupin Ltd and Enzene Biosciences in India, he has extensive experience in all aspects of process development and cGMP production of therapeutic biologics. Samir holds a MS in Biochemical Engineering from Drexel University, Philadelphia and a MBA from New York University, New York. He currently heads the Manufacturing Department at Enzene Biosciences. Enzene Biosciences is a full owned subsidiary of Alkem Laboratories and is based in Pune, India.



Sponsored by GE Healthcare


About GE Healthcare Life Sciences
The Life Sciences business of GE Healthcare provides a wide range of bioprocessing products and services that enable the development and manufacture of high-quality biotherapeutics and vaccines. Using our knowledge and expertise, we support our customers in increasing speed to market, while avoiding unnecessary costs and improving quality and performance in drug manufacturing.  As a provider of high-quality products, customized technical and commercial services, as well as design and construction of complete biomanufacturing solutions, we support the biopharmaceutical industry in making health visions a reality.